NATO Defense Spending Surge and US Troop Deployment to Poland Signal Shift in European Security
London Stock Exchange Group Reports Income Growth Driven by Tradeweb Performance
UK Exports to US Plunge 25 Following Trump Tariff Announcement
Fraudsters Forged Paperwork Too Modern Foils Fake Statue Scheme at Sothebys
Billionaire Philippe Laffont Rotates from Cloud Giants to AI Chip Infrastructure
Nvidias Earnings Reveal 200 Billion Edge Computing Opportunity Amid China Market Retreat
OXM Q1 2026 Earnings Major EPS Miss but Stock Surges 8
TYRA Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Continues RD Investment
NVCR Q1 2026 Earnings WiderThanExpected Loss Fails to Dampen Investor Sentiment
ABNB Q1 2026 Earnings EPS Falls Short as Stock Dips Modestly
PermaFix Environmental Services PESI Q1 2026 Earnings Significant EPS Miss Amid No Reported Revenue
Recursion Pharmaceuticals RXRX Q1 2026 Earnings Narrower Loss Surprises Market but Stock Dips on PreRevenue Status
Satellogic Warrants SATLW Plunge 11 Key Support Levels in Focus
Spectral AI Inc MDAI Edges Higher Nearing Key Resistance as Momentum Shifts
Adobe Inc ADBE Edges Higher Amid Consolidation Holds Above Key Support
Smurfit WestRock SW Holds Steady Near MidRange as Investors Eye Resistance Levels
Linkhome Holdings Inc LHAI Holds Steady at 090 as Key Levels Define Trading Range
USA Rare Earth Surges 13 Amid USChina Trade Deal Uncertainty
VUZI Q1 2026 Earnings EPS Beat and Narrowed Loss Boost Investor Sentiment
NexPoint Residential Trust NXRT Slides Slightly While Holding Above Key Support Levels
Coty Q1 2026 Earnings A Narrow EPS Miss Amid Lingering Challenges
Instil Bio Q1 2026 Earnings EPS Miss as DevelopmentStage Company Reports No Revenue Stock Edges Up
SSC Technologies SSNC Q1 2026 Earnings EPS Slightly Beats Estimates Despite Modest Stock Decline
QURE Q1 2026 Earnings Narrower Loss Than Expected but Stock Declines on Lack of Revenue
OCSL Q1 2026 Earnings EPS Beats Estimates Stock Gains
Processa Pharmaceuticals Inc PCSA Q4 2025 Earnings EPS Misses Estimates as Biotech Focuses on Clinical Pipeline
YELP Q1 2026 Earnings EPS Beat by 117 Amid Modest Stock Uptick